Equity Analysis

Quarterly Results

    Windlas Biotech Ltd
    Industry :  Pharmaceuticals - Indian - Formulations
    BSE Code
    ISIN Demat
    Book Value()
    543329
    INE0H5O01029
    215.4715093
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    WINDLAS
    39.26
    2338.43
    EPS(TTM)
    Face Value()
    Div & Yield %:
    28.5
    5
    0.49
     
Quarters
(RupeeIcon Cr)
ParticularsJun 2024Mar 2024Dec 2023
Gross Sales175.15171.29162.21
Other Operating Income0.000.000.00
Other Income 4.134.443.16
Total Income179.29175.73165.38
Total Expenditure 154.27149.35141.88
PBIDT25.0126.3823.50
Interest 0.490.280.31
PBDT24.5226.1023.20
Depreciation6.213.543.39
Tax4.614.524.47
Fringe Benefit Tax0.000.000.00
Deferred Tax0.221.090.24
Reported Profit After Tax13.4816.9515.10
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item13.4816.9515.10
EPS (Unit Curr.)6.478.157.26
EPS (Adj) (Unit Curr.)6.478.157.26
Calculated EPS (Unit Curr.)6.458.157.26
Calculated EPS (Adj) (Unit Curr.)6.458.157.26
Calculated EPS (Ann.) (Unit Curr.)25.8032.6029.04
Calculated EPS (Adj) (Ann.) (Unit Curr.)25.8032.6029.04
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity10.4510.4010.40
Reserve & Surplus0.000.000.00
Face Value5.005.005.00
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
PBIDTM(%)14.2815.4014.49
PBDTM(%)14.0015.2414.30
PATM(%)7.709.909.31
Dividend Per Share(Rs)0.000.000.00
Diluted EPS6.448.127.26